On Wednesday, the U.S. Department of Health and Human Services announced its timeline for the Medicare Drug Price Negotiation Program, a key point of legislation in the Inflation Reduction Act (IRA).
In a press call, Centers for Medicare and Medicaid Services (CMS) Administrator Chiquita Brooks-LaSure said that the department will...